Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Kiltearn Partners LLP

Kiltearn Partners LLP cut its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 17.6% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,059,500 shares of the pharmacy operator’s stock after selling 226,100 shares during the quarter. Walgreens Boots Alliance accounts for about 1.6% of Kiltearn Partners LLP’s portfolio, making the stock its 26th largest holding. Kiltearn Partners LLP owned about 0.12% of Walgreens Boots Alliance worth $12,815,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Pineridge Advisors LLC acquired a new stake in Walgreens Boots Alliance during the 4th quarter worth $26,000. Quest Partners LLC acquired a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth approximately $30,000. 1832 Asset Management L.P. lifted its holdings in Walgreens Boots Alliance by 282.1% in the fourth quarter. 1832 Asset Management L.P. now owns 1,219 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 900 shares during the last quarter. New Covenant Trust Company N.A. purchased a new position in Walgreens Boots Alliance in the first quarter worth approximately $35,000. Finally, First Personal Financial Services increased its stake in Walgreens Boots Alliance by 260.0% during the first quarter. First Personal Financial Services now owns 1,800 shares of the pharmacy operator’s stock worth $39,000 after acquiring an additional 1,300 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $8.56 on Tuesday. The firm has a market capitalization of $7.39 billion, a price-to-earnings ratio of -1.27, a PEG ratio of 1.02 and a beta of 0.70. The firm’s fifty day simple moving average is $10.23 and its 200-day simple moving average is $14.59. Walgreens Boots Alliance, Inc. has a twelve month low of $8.46 and a twelve month high of $27.05. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing the consensus estimate of $0.68 by ($0.05). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company had revenue of $36.40 billion during the quarter, compared to analysts’ expectations of $35.94 billion. During the same quarter in the prior year, the company earned $1.00 earnings per share. The business’s revenue for the quarter was up 2.8% on a year-over-year basis. Equities analysts forecast that Walgreens Boots Alliance, Inc. will post 2.86 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Wednesday, August 21st were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 11.68%. The ex-dividend date of this dividend was Wednesday, August 21st. Walgreens Boots Alliance’s dividend payout ratio is currently -14.84%.

Analysts Set New Price Targets

WBA has been the subject of a number of recent analyst reports. Morgan Stanley cut their price objective on Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating for the company in a research report on Friday, June 28th. Bank of America dropped their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. UBS Group decreased their price objective on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a report on Wednesday, July 3rd. Truist Financial lowered their price objective on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a research report on Friday, June 28th. Finally, Royal Bank of Canada decreased their price target on Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating on the stock in a research note on Tuesday, July 2nd. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Walgreens Boots Alliance has an average rating of “Hold” and a consensus target price of $14.73.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.